The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,435,295 in first-year total cost, median $224,686.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-2 (O3)]4
Most frequent institutions
- DOSE SAFETY COMPANY1
- GLYSENS, INC.1
- SILICON KIDNEY, LLC1
- TYPEZERO TECHNOLOGIES, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Use of Dose Safety Controller (DSC) Artificial Pancreas in Subjects with Hypoglycemia Unawareness2R44DK104317-03 | MAUSETH, RICHARD SCOTT | DOSE SAFETY COMPANY, WA | $761,569 | ZDK1 |
| 2014 | Replaceable Long Term Implanted Glucose Sensor1R43DK104296-01 | LUCISANO, JOSEPH Y. | GLYSENS, INC., CA | $225,000 | ZDK1 |
| 2014 | An Intravascular Bioartificial Pancreas (iBAP)1R43DK104299-01 | BLAHA, CHARLES | SILICON KIDNEY, LLC, CA | $224,372 | ZDK1 |
| 2014 | Development of a Centralized Intelligence and Control AP Hub Device1R43DK104293-01 | KELLER, JEFFREY | TYPEZERO TECHNOLOGIES, LLC, VA | $224,354 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.